BONE MARROW FAILURE
Clinical trials for BONE MARROW FAILURE explained in plain language.
Never miss a new study
Get alerted when new BONE MARROW FAILURE trials appear
Sign up with your email to follow new studies for BONE MARROW FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy aims to make risky cancer transplants safer
Disease control OngoingThis early-stage trial is testing whether adding specially treated immune cells, called 'veto cells,' can help patients with blood cancers or bone marrow failure after a stem cell transplant. The goal is to help the donor's cells grow in the patient's body without causing a dange…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 21:11 UTC
-
Early trial tests cell therapy for rare blood disorder
Disease control OngoingThis early-stage study is testing the safety of an experimental cell therapy called EXG34217 in up to 12 patients with a rare genetic disorder that causes bone marrow failure. The therapy involves collecting a patient's own blood cells, modifying them in a lab to potentially leng…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC